PD-L1 as a predictive factor for non-small-cell lung cancer prognosis
Long Chen1, Xian-Ze Zhu2, Shi-Jie Zhao1
1ENT & HN Surgery Department, The Third Affiliated Hospital of Guangxi Medical University, Nanning 530033, China.
The Lancet. Oncology
|May 31, 2024
Abstract
No abstract available in PubMed .
More Related Videos
07:43Using 22C3 Anti-PD-L1 Antibody Concentrate on Biopsy and Cytology Samples from Non-small Cell Lung Cancer Patients
Published on: September 25, 2018
10.6K
07:42Patient-Derived Tumor Explants As a "Live" Preclinical Platform for Predicting Drug Resistance in Patients
Published on: February 7, 2021
4.9K
